These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 5357297)

  • 21. The fatty acid composition of serum total lipids and lipid fractions in coronary heart disease and cerebral atherosclerosis.
    Abdel Hay A; Kramer M; Keller L; Retsagi G
    J Egypt Med Assoc; 1970; 53(5):309-20. PubMed ID: 5506287
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of blood cholesterol in atherosclerosis and coronary heart disease.
    Sherwin R; Lewis C; Russell RP
    Md Med J; 1986 Apr; 35(4):248-50. PubMed ID: 3713460
    [No Abstract]   [Full Text] [Related]  

  • 23. [Paper electrophoresis and arteriography in arteriosclerotic and endangitic arterial occlusions].
    VOIGT KD; SCHRADER EA
    Z Kreislaufforsch; 1954 Jan; 43(1-2):2-11. PubMed ID: 13170390
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of Halidor on serum lipid fractions in patients with coronary disease and cerebrovascular sclerosis].
    Krámer M; Keller L; Molnár G
    Orv Hetil; 1968 May; 109(21):Suppl:42-3. PubMed ID: 5720723
    [No Abstract]   [Full Text] [Related]  

  • 25. Lowering cholesterol levels in patients with coronary heart disease. The LIPID Study Management Committee.
    Med J Aust; 1995 May; 162(9):455-6. PubMed ID: 7746199
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lipid therapy. Goal and use in prevention of coronary heart disease].
    Windler E; Greten H
    Internist (Berl); 1996 Dec; 37(12):1244-8. PubMed ID: 9081925
    [No Abstract]   [Full Text] [Related]  

  • 27. [Activity of lecithin-cholesterol-acyltransferase in patients with arteriosclerosis].
    Bavina MV; Torkhovskaia TI; Lobova NM; Tsymbaliuk IK
    Ter Arkh; 1973; 45(6):76-81. PubMed ID: 4795177
    [No Abstract]   [Full Text] [Related]  

  • 28. [Lipoproteins in plasma and fats in nutrition in the pathogenesis of coronary heart disease. Remarks on the causes and limits of the lipid theory].
    Zöllner N; Keller C
    Internist (Berl); 1984 May; 25(5):261-7. PubMed ID: 6376406
    [No Abstract]   [Full Text] [Related]  

  • 29. [Fatty acid makeup of different lipid fractions of plasma lipoproteins in persons dying suddenly from coronary heart disease].
    Aptekar' SG
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):36-42. PubMed ID: 7259866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Blood lipids in patients with coronary atherosclerosis].
    Bordiuk TV
    Sov Med; 1972 Nov; 35(11):142-3. PubMed ID: 4667488
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipids and atherosclerosis. A two-pronged approach to treatment.
    Tzagournis M
    Postgrad Med; 1987 May; 81(6):242-9, 252. PubMed ID: 3575196
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
    el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN
    J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents].
    De Caterina R; Lenzi S
    G Ital Cardiol; 1998 Feb; 28(2):168-77. PubMed ID: 9534058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipids, lipoproteins, apolipoproteins, and atherosclerosis.
    Kreisberg RA
    Ann Intern Med; 1983 Nov; 99(5):713-5. PubMed ID: 6638729
    [No Abstract]   [Full Text] [Related]  

  • 35. [BLOOD LIPIDS IN ATHEROSCLEROSIS AND THE ACTION OF SOME AGENTS MODIFYING LIPEMIA].
    VASTESAEGER MM
    Acta Gastroenterol Belg; 1964 Jul; 27():398-407. PubMed ID: 14223522
    [No Abstract]   [Full Text] [Related]  

  • 36. [Conservative treatment and prevention of arteriosclerosis].
    Schmid HJ
    Helv Chir Acta; 1971 Apr; 38(1):73-7. PubMed ID: 4103070
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of essential phospholipids on the lipid spectrum of blood plasma and the aggregative capacity of thrombocytes in patients with ischemic heart disease].
    Botolova EN; Solov'ev VV; Ozerova IN; Polesskiĭ VA; Pomykalov SV
    Kardiologiia; 1988 Sep; 28(9):57-61. PubMed ID: 3236647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CONTRIBUTION TO THE STUDY OF THE THERAPY OF ATHEROSCLEROSIS WITH ESSENTIAL PHOSPHOLIPIDS].
    PUPITA F; RAPPELLI A; VACCARINO A; OBERHOFFER G
    Clin Ter; 1964 Jan; 28():120-36. PubMed ID: 14122515
    [No Abstract]   [Full Text] [Related]  

  • 39. [Influence of combined, hypolipemic therapy on lipids and non-lipid atherosclerosis risk factors].
    Broncel M; Balcerak M; Chojnowska-Jezierska J
    Pol Merkur Lekarski; 2007 Jan; 22(127):62-5. PubMed ID: 17477094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum lipid fractions and risk of coronary heart disease. The Framingham study.
    Kannel WB; Castelli WP; McNamara PM
    Minn Med; 1969 Aug; 52(8):1225-30. PubMed ID: 5804989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.